{
  "slug": "nanograb",
  "name": "Nanograb",
  "yc_id": 29051,
  "batch": "Summer 2023",
  "website": "https://nanograb.com",
  "web_data": {
    "web_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T01:25:58.546708",
    "website": "https://nanograb.com",
    "website_status": {
      "reachable": true,
      "status_code": 200,
      "response_time_ms": 1533.43,
      "final_url": "https://nanograb.com/",
      "redirected": true,
      "checked_at": "2025-10-17T01:26:00.080147"
    },
    "ssl_security": {
      "disabled": true,
      "reason": "certificate_verification_failed"
    },
    "domain_info": {
      "domain": "nanograb.com",
      "registrar": "Squarespace Domains II LLC",
      "creation_date": "2022-01-18T02:18:10",
      "expiration_date": "2026-01-18T02:18:10",
      "domain_age_days": 1367,
      "domain_age_years": 3.7,
      "name_servers": [
        "NS-CLOUD-D1.GOOGLEDOMAINS.COM",
        "NS-CLOUD-D2.GOOGLEDOMAINS.COM",
        "NS-CLOUD-D3.GOOGLEDOMAINS.COM",
        "NS-CLOUD-D4.GOOGLEDOMAINS.COM"
      ]
    },
    "social_links": {
      "twitter": null,
      "linkedin": null,
      "github": null,
      "facebook": null,
      "instagram": null,
      "youtube": null
    },
    "security_headers": {
      "strict_transport_security": true,
      "content_security_policy": false,
      "x_frame_options": true,
      "x_content_type_options": true,
      "x_xss_protection": true,
      "referrer_policy": false,
      "security_score": 66,
      "server": "Caddy, nginx"
    }
  },
  "enrichment_version": "1.0.0",
  "enriched_at": "2025-10-17T10:40:52.866341",
  "phase1_complete": true,
  "phase2_complete": false,
  "phase3_complete": false,
  "phase4_complete": false,
  "phase5_complete": false,
  "ai_insights": {
    "ai_insights_version": "1.0.0",
    "model_used": "google/gemini-2.0-flash-001",
    "enriched_at": "2025-10-17T12:41:52.011652",
    "status": "success",
    "market_analysis": {
      "market_size": "very large",
      "market_stage": "growing",
      "key_trends": [
        "AI in drug discovery",
        "Personalized medicine",
        "Targeted drug delivery systems"
      ]
    },
    "competitive_positioning": {
      "competitive_moat": "Proprietary AI algorithms and generated binder libraries create a technological moat. Early mover advantage in a rapidly evolving field.",
      "differentiation": "AI-driven binder generation for highly specific drug targeting, potentially reducing side effects and improving efficacy.",
      "competitive_advantages": [
        "AI-driven discovery process",
        "Targeted drug delivery capabilities"
      ],
      "competitive_vulnerabilities": [
        "Reliance on AI accuracy and validation",
        "Competition from established pharma companies with large R&D budgets"
      ]
    },
    "business_model": {
      "revenue_model": "SaaS",
      "scalability": "high",
      "capital_intensity": "medium"
    },
    "growth_assessment": {
      "growth_stage": "seed",
      "growth_indicators": [
        "Partnerships with pharmaceutical companies",
        "Successful preclinical trial results"
      ],
      "growth_bottlenecks": [
        "Regulatory hurdles for new drug delivery systems",
        "Scaling AI infrastructure and data management"
      ]
    },
    "risk_analysis": {
      "market_risk": "medium",
      "technology_risk": "high",
      "execution_risk": "medium",
      "overall_risk_score": 7,
      "key_risks": [
        "AI algorithm limitations",
        "Clinical trial failures",
        "Competition from alternative drug delivery methods"
      ]
    },
    "investment_thesis": {
      "strengths": [
        "Strong founding team with AI and drug discovery expertise",
        "Potential to revolutionize drug delivery",
        "Large and growing market"
      ],
      "concerns": [
        "High technology risk",
        "Long development timelines and regulatory approval processes"
      ],
      "exit_potential": "acquisition",
      "comparable_companies": [
        "Schr\u00f6dinger",
        "Atomwise"
      ]
    },
    "recommendations": {
      "next_steps": [
        "Secure partnerships with pharmaceutical companies for drug development",
        "Conduct rigorous preclinical and clinical trials to validate technology"
      ],
      "expansion_opportunities": [
        "Expand AI platform to target new disease areas",
        "Develop proprietary drug delivery devices"
      ]
    },
    "tokens_used": {
      "prompt": 647,
      "completion": 607,
      "total": 1254,
      "estimated_cost": 0.000231
    }
  },
  "phase8_complete": true
}